Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10391)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2013 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hu LS, George J, Wang JH. Current concepts on the role of nitric oxide in portal hypertension. World J Gastroenterol 2013; 19(11): 1707-1717 [PMID: 23555159 DOI: 10.3748/wjg.v19.i11.1707] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i11/1707.htm |
| Number | Citing Articles |
| 1 |
Raffaele Licinio, Giuseppe Losurdo, Sonia Carparelli, Andrea Iannone, Floriana Giorgio, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo. Helicobacter pylori, liver cirrhosis, and portal hypertension: an updated appraisal. Immunopharmacology and Immunotoxicology 2016; 38(6): 408 doi: 10.1080/08923973.2016.1247855
|
| 2 |
Abdelmonem A. Hegazy, Marwa M. Ahmed, Mohammed A. Shehata, Marwa M Abdelfattah, Yuksel Aydar. Changes in Rats’ Liver Structure Induced by Zinc Oxide Nanoparticles and the Possible Protective Role of Vitamin E. International Journal of Human Anatomy 2018; 1(3): 1 doi: 10.14302/issn.2577-2279.ijha-18-2384
|
| 3 |
Sergi Guixé-Muntet, Sergio Quesada-Vázquez, Jordi Gracia-Sancho. Pathophysiology and therapeutic options for cirrhotic portal hypertension. The Lancet Gastroenterology & Hepatology 2024; 9(7): 646 doi: 10.1016/S2468-1253(23)00438-7
|
| 4 |
Gülsüm Özlem Elpek. Angiogenesis and liver fibrosis. World Journal of Hepatology 2015; 7(3): 377-391 doi: 10.4254/wjh.v7.i3.377
|
| 5 |
Francesco Violi, Pasquale Pignatelli, Valentina Castellani, Roberto Carnevale, Vittoria Cammisotto. Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis. Blood Reviews 2023; 57: 100998 doi: 10.1016/j.blre.2022.100998
|
| 6 |
Juan Cristóbal Gana, Carolina A. Serrano, Simon C. Ling. Angiogenesis and portal-systemic collaterals in portal hypertension. Annals of Hepatology 2016; 15(3): 303 doi: 10.5604/16652681.1198799
|
| 7 |
Nermin Raafat, Sara M. Abdel Aal, Fadia K. Abdo, Nabila M. El Ghonaimy. Mesenchymal stem cells: In vivo therapeutic application ameliorates carbon tetrachloride induced liver fibrosis in rats. The International Journal of Biochemistry & Cell Biology 2015; 68: 109 doi: 10.1016/j.biocel.2015.09.003
|
| 8 |
Mega Obukohwo Oyovwi, Adedeji David Atere. Exploring the medicinal significance of l-Arginine mediated nitric oxide in preventing health disorders. European Journal of Medicinal Chemistry Reports 2024; 12: 100175 doi: 10.1016/j.ejmcr.2024.100175
|
| 9 |
Siwei Tan. Molecular mechanism of portal hypertensive gastropathy: An update. Clinics and Research in Hepatology and Gastroenterology 2024; 48(8): 102423 doi: 10.1016/j.clinre.2024.102423
|
| 10 |
Dmitry Victorovich Garbuzenko. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis. World Journal of Gastroenterology 2015; 21(20): 6117-6126 doi: 10.3748/wjg.v21.i20.6117
|
| 11 |
Mohammad A. Aboul-Ezz, Ali Abdel Rahim, Ahmed El-Mikkawy, Mohammad A. Elkady, Mohamed. A Elrefaiy, Samia El-Shishtawy, Osama Mosbah, Khaled Mabrouk, Mostafa Elshafie, Omar M. Sabry. Hepatorenal Syndrome: A Way for Early and Accurate Diagnosis. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 1979 doi: 10.3889/oamjms.2022.9675
|
| 12 |
Sophie Restellini, Nicolas Goossens, Sophie Clément, Nicolas Lanthier, Francesco Negro, Laura Rubbia-Brandt, Laurent Spahr. Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease. World Journal of Hepatology 2018; 10(1): 73-81 doi: 10.4254/wjh.v10.i1.73
|
| 13 |
Theresa Bucsics, Elisabeth Krones. Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome. Gastroenterology Report 2017; 5(2): 127 doi: 10.1093/gastro/gox009
|
| 14 |
Marek Saracyn, Marek Brytan, Robert Zdanowski, Tomasz Ząbkowski, Przemysław Dyrla, Janusz Patera, Stanisław Wojtuń, Wojciech Kozłowski, Zofia Wańkowicz. Hepatoprotective effect of nitric oxide in experimental model of acute hepatic failure. World Journal of Gastroenterology 2014; 20(46): 17407-17415 doi: 10.3748/wjg.v20.i46.17407
|
| 15 |
L. Lorente, F. Gómez-Bernal, M.M. Martín, J.A. Navarro-Gonzálvez, M. Argueso, A. Perez, L. Ramos-Gómez, J. Solé-Violán, J.A. Marcos y Ramos, N. Ojeda, A. Jiménez. High serum nitrates levels in non-survivor COVID-19 patients. Medicina Intensiva (English Edition) 2022; 46(3): 132 doi: 10.1016/j.medine.2020.10.007
|
| 16 |
Khalid M. Al Syaad, Amin A. Al-Doaiss, Ahmed Ezzat Ahmed, Haitham El-Mekkawy, Mohamed Abdelrahman, Ahmed A. El-Mansi, Muhammad Fakhar-e-Alam Kulyar, Montaser Elsayed Ali. The abrogative effect of propolis on acrylamide-induced toxicity in male albino rats: Histological study. Open Chemistry 2023; 21(1) doi: 10.1515/chem-2022-0321
|
| 17 |
Wolfgang Kreisel, Denise Schaffner, Adhara Lazaro, Jonel Trebicka, Irmgard Merfort, Annette Schmitt-Graeff, Peter Deibert. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension. International Journal of Molecular Sciences 2020; 21(17): 6223 doi: 10.3390/ijms21176223
|
| 18 |
Mahmoud Sobh, Mohamed Abdalbary, Mostafa Abdelsalam, Amr El-Husseini Mohamed. Renal Dysfunction in Patients with Liver Cirrhosis. Digestive Disease Interventions 2022; 6(02): 131 doi: 10.1055/s-0042-1746192
|
| 19 |
Geert Peeters, Charlotte Debbaut, Adrian Friebel, Pieter Cornillie, Winnok H. De Vos, Kasper Favere, Ingrid Vander Elst, Tim Vandecasteele, Tim Johann, Luc Van Hoorebeke, Diethard Monbaliu, Dirk Drasdo, Stefan Hoehme, Wim Laleman, Patrick Segers. Quantitative analysis of hepatic macro‐ and microvascular alterations during cirrhogenesis in the rat. Journal of Anatomy 2018; 232(3): 485 doi: 10.1111/joa.12760
|
| 20 |
Liangshuo Hu, Lin Su, Zhixia Dong, Yunhua Wu, Yi Lv, Jacob George, Jianhua Wang. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model. Journal of Molecular Medicine 2019; 97(3): 423 doi: 10.1007/s00109-019-01746-4
|
| 21 |
Wolfgang Kreisel, Adhara Lazaro, Jonel Trebicka, Markus Grosse Perdekamp, Annette Schmitt-Graeff, Peter Deibert. Cyclic GMP in Liver Cirrhosis—Role in Pathophysiology of Portal Hypertension and Therapeutic Implications. International Journal of Molecular Sciences 2021; 22(19): 10372 doi: 10.3390/ijms221910372
|
| 22 |
Meritxell Perramón, María Navalón-López, Guillermo Fernández-Varo, Alazne Moreno-Lanceta, Rocío García-Pérez, Joana Faneca, Mario López-Moya, Cristina Fornaguera, Judith García-Villoria, Manuel Morales-Ruiz, Pedro Melgar-Lesmes, Salvador Borrós, Wladimiro Jiménez. Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats. Biomedicine & Pharmacotherapy 2024; 171: 116143 doi: 10.1016/j.biopha.2024.116143
|
| 23 |
Kamil Kus, Maria Walczak, Edyta Maslak, Agnieszka Zakrzewska, Anna Gonciarz-Dytman, Piotr Zabielski, Barbara Sitek, Krystyna Wandzel, Agnieszka Kij, Adrian Chabowski, Ryan J. Holland, Joseph E. Saavedra, Larry K. Keefer, Stefan Chlopicki. Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics. Drug Metabolism and Disposition 2015; 43(7): 1028 doi: 10.1124/dmd.115.063388
|
| 24 |
Atsushi Kawamura, Haruki Uojima, Makoto Chuma, Xue Shao, Hisashi Hidaka, Takahide Nakazawa, Akira Take, Yoshihiko Sakaguchi, Kazushi Numata, Makoto Kako, Akito Nozaki, Shintaro Azuma, Kazue Horio, Chika Kusano, Koichiro Atsuda. The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10002-x
|
| 25 |
Ming-li Zhu, Wei Wang, Feng Qin, Yong Chen. Effects and mechanism of total phenols of Magnolia officinalis combined with Maijunan Tablets on blood pressure of spontaneous hypertensive rats. Chinese Herbal Medicines 2019; 11(2): 177 doi: 10.1016/j.chmed.2018.12.004
|
| 26 |
Simona Bartimoccia, Michael Praktiknjo, Cristina Nocella, Robert Schierwagen, Vittoria Cammisotto, Christian Jansen, Luca Cristiano, Valentina Castellani, Johannes Chang, Roberto Carnevale, Sofia Maiucci, Frank Erhard Uschner, Pasquale Pignatelli, Maximilian Joseph Brol, Jonel Trebicka, Francesco Violi. Association between endotoxemia and blood no in the portal circulation of cirrhotic patients: results of a pilot study. Internal and Emergency Medicine 2024; 19(3): 713 doi: 10.1007/s11739-024-03534-6
|
| 27 |
L. Lorente, F. Gómez-Bernal, M.M. Martín, J.A. Navarro-Gonzálvez, M. Argueso, A. Perez, L. Ramos-Gómez, J. Solé-Violán, J.A. Marcos y Ramos, N. Ojeda, A. Jiménez. High serum nitrates levels in non-survivor COVID-19 patients. Medicina Intensiva 2022; 46(3): 132 doi: 10.1016/j.medin.2020.10.003
|
| 28 |
Francielli Licks, Renata Minuzzo Hartmann, Camila Marques, Elizângela Schemitt, Josieli Raskopf Colares, Mariana do Couto Soares, Juliana Reys, Camila Fisher, Juliana da Silva, Norma Possa Marroni. N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats. World Journal of Gastroenterology 2015; 21(43): 12351-12360 doi: 10.3748/wjg.v21.i43.12351
|
| 29 |
Maro Dragičević, Iva Košuta, Egon Kruezi, Marijana Vučić Lovrenčić, Anna Mrzljak. Association of Asymmetric Dimethylarginine and Nitric Oxide with Cardiovascular Risk in Patients with End-Stage Liver Disease. Medicina 2020; 56(11): 622 doi: 10.3390/medicina56110622
|
| 30 |
Ravi Tyagi, Ana Gonzalez, Divya Meher Surabhi, Rakesh Navuluri. Transjugular Intrahepatic Portosystemic Shunt. Contemporary Diagnostic Radiology 2022; 45(18): 1 doi: 10.1097/01.CDR.0000856520.01226.68
|
| 31 |
Frank E. Uschner, Kathleen Glückert, Rafael Paternostro, Thorsten Gnad, Robert Schierwagen, Mattias Mandorfer, Fernando Magdaleno, Cristina Ortiz, Katharina Schwarzkopf, Patrick S. Kamath, Carlo Alessandria, Christoph Boesecke, Alexander Pfeifer, Thomas Reiberger, Wolfgang Kreisel, Tilman Sauerbruch, Arnulf Ferlitsch, Jonel Trebicka, Sabine Klein. Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction. Liver International 2020; 40(9): 2228 doi: 10.1111/liv.14586
|
| 32 |
Sergio Maimone, Francesca Saffioti, Giovanni Oliva, Antonino Di Benedetto, Angela Alibrandi, Roberto Filomia, Gaia Caccamo, Carlo Saitta, Irene Cacciola, Concetta Pitrone, Giovanni Squadrito, Giovanni Raimondo. Erectile dysfunction in compensated liver cirrhosis. Digestive and Liver Disease 2019; 51(6): 843 doi: 10.1016/j.dld.2018.10.015
|
| 33 |
G. Jayakumar Amirtharaj, Kavitha R. Thangaraj, Archana Kini, Raghupathy V., Ashish Goel, Eapen C.E., Aparna Venkatraman, Anna B. Pulimood, Balasubramanian K.A., Anup Ramachandran. Acute liver injury induced by low dose dimethylnitrosamine alters mediators of hepatic vascular flow. Toxicology Reports 2014; 1: 707 doi: 10.1016/j.toxrep.2014.09.001
|
| 34 |
Francielli Licks, Renata Minuzzo Hartmann, Elizângela Schemitt, Josieli Raskopf Colares, Lúcio Sarubbi Fillmann, Henrique Fillmann, Norma Possa Marroni. Inflammatory bowel and oxidative stress changes in an experimental model of portal hypertension: action of N-acetylcysteine. Journal of Coloproctology 2016; 36(04): 231 doi: 10.1016/j.jcol.2016.05.005
|
| 35 |
Robert E. Smith, Alice D. Friedman, James A. Murchison, S. Blake Tanner, P. Alexander Smith, Bradley T. Dollar. Acute Life-Threatening Complications of Portal Hypertension: a Review of Pathophysiology, Incidence, Management, and Cost. SN Comprehensive Clinical Medicine 2020; 2(9): 1628 doi: 10.1007/s42399-020-00435-5
|
| 36 |
М. Abrahamovych, О. Abrahamovych, M. Farmaha. The content of some vasoactive humoral-metabolic factors in patients with cirrhosis and their participation in pathogenesis of comorbid syntropical damages of cardiovascular system. Lviv clinical bulletin 2017; 4(20): 40 doi: 10.25040/lkv2017.04.040
|
| 37 |
Michele Molinari, Carlos Fernandez‐Carrillo, Dongling Dai, Jorgensen Dana, Ana Clemente‐Sanchez, Stalin Dharmayan, Christof Kaltenmeier, Hao Liu, Jaideep Behari, Vikrant Rachakonda, Swaytha Ganesh, Christopher Hughes, Amit Tevar, Hasan Al Harakeh, Bishoy Emmanuel, Abhinav Humar, Ramon Bataller. Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis. Transplant International 2021; 34(6): 1105 doi: 10.1111/tri.13873
|
| 38 |
|
| 39 |
Cheng-Gang Zhang, Bin Zhang, Wen-Sheng Deng, Ming Duan, Wei Chen, Zhi-Yong Wu. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl<sub>4</sub>-induced liver cirrhosis. World Journal of Gastroenterology 2016; 22(18): 4484-4500 doi: 10.3748/wjg.v22.i18.4484
|
| 40 |
Marco Di Pascoli, David Sacerdoti, Patrizia Pontisso, Paolo Angeli, Massimo Bolognesi. Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis. Journal of Vascular Research 2017; 54(2): 92 doi: 10.1159/000462974
|
| 41 |
Ali A. A. Al-Ali, Shatha Q. Al-Tamimi, Sami J. Al-Maliki, Mohd Azmuddin Abdullah. Toxic effects of zinc oxide nanoparticles and histopathological and caspase-9 expression changes in the liver and lung tissues of male mice model. Applied Nanoscience 2022; 12(2): 193 doi: 10.1007/s13204-021-02248-x
|
| 42 |
Nicholas G Theodorakis, Yining N Wang, Vyacheslav A Korshunov, Mary A Maluccio, Nicholas J Skill. Thalidomide ameliorates portal hypertension <italic>via</italic> nitric oxide synthase independent reduced systolic blood pressure. World Journal of Gastroenterology 2015; 21(14): 4126-4135 doi: 10.3748/wjg.v21.i14.4126
|
| 43 |
D. V. Garbuzenko. Aspects of pathogenetic pharmacotherapy for portal hypertension in liver cirrhosis. Terapevticheskii arkhiv 2016; 88(2): 101 doi: 10.17116/terarkh2016888101-108
|
| 44 |
Ahmed Abdel-Razik, Nasser Mousa, Rania Elhelaly, Rasha Elzehery, Ahmad S. Hasan, Mostafa Abdelsalam, Ahmed Salah Seif, Ahmed M. Tawfik, Niveen El-Wakeel, Waleed Eldars. Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00096
|
| 45 |
Antony Sameh Mansour. Autoregulation: mediators and renin–angiotensin system in diseases and treatments. Future Journal of Pharmaceutical Sciences 2023; 9(1) doi: 10.1186/s43094-023-00482-4
|
| 46 |
Mohammed Ahmed Shehata Amin, Hany M. A. Sonpol, Rehab Hassan Elbanna Gouda, Adel Mohamed Aboregela. Bisphenol A enhances apoptosis, fibrosis, and biochemical fluctuations in the liver of adult male rats with possible regression after recovery. The Anatomical Record 2023; 306(1): 213 doi: 10.1002/ar.25032
|
| 47 |
Rakesh Sahu, Rakhi Mishra, Chandana Majee. An insight into primary biliary cholangitis and its recent advances in treatment: semi-synthetic analogs to combat ursodeoxycholic-acid resistance. Expert Review of Gastroenterology & Hepatology 2020; 14(10): 985 doi: 10.1080/17474124.2020.1797485
|
| 48 |
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev, Dmitry Vladimirovich Belov. Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis. World Journal of Hepatology 2016; 8(16): 665-672 doi: 10.4254/wjh.v8.i16.665
|
| 49 |
Remi Neviere, Pierre Trinh-Duc, Sébastien Hulo, Jean Louis Edme, Aurélie Dehon, Emmanuel Boleslawski, Sébastien Dharancy, Gilles Lebuffe. Predictive value of exhaled nitric oxide and aerobic capacity for sepsis complications after liver transplantation. Transplant International 2016; 29(12): 1307 doi: 10.1111/tri.12861
|
| 50 |
Alagappan Annamalai, Lauren Wisdom, Megan Herada, Mazen Noureddin, Walid Ayoub, Vinay Sundaram, Andrew Klein, Nicholas Nissen. Management of refractory ascites in cirrhosis: Are we out of date?. World Journal of Hepatology 2016; 8(28): 1182-1193 doi: 10.4254/wjh.v8.i28.1182
|
| 51 |
Xi Chen, I. Tong Mak. Mg supplementation protects against ritonavir-mediated endothelial oxidative stress and hepatic eNOS downregulation. Free Radical Biology and Medicine 2014; 69: 77 doi: 10.1016/j.freeradbiomed.2014.01.011
|
| 52 |
Yavuz Beyazit, Cumali Efe, Alpaslan Tanoglu, Tugrul Purnak, Abdurrahim Sayilir, Ismail Taskıran, Murat Kekilli, Turan Turhan, Ersan Ozaslan, Staffan Wahlin. Nitric oxide is a potential mediator of hepatic inflammation and fibrogenesis in autoimmune hepatitis. Scandinavian Journal of Gastroenterology 2015; 50(2): 204 doi: 10.3109/00365521.2014.974203
|
| 53 |
Abeer F. Abdel-Mohsen, Nagla M. Salama, Mohamed S. Elgendy, Asmaa M. Elsayed. Histological study on the effect of stem cells and hepatocyte growth factor on induced liver fibrosis in male albino rats. The Egyptian Journal of Histology 2014; 37(4): 615 doi: 10.1097/01.EHX.0000455823.96943.24
|
| 54 |
Ashish Goel, P. L. Alagammai, Sukesh C. Nair, Ian Mackie, Banumathi Ramakrishna, Jayaprakash Muliyil, Shyamkumar N. Keshava, C. E. Eapen, Elwyn Elias. ADAMTS13 deficiency, despite well-compensated liver functions in patients with noncirrhotic portal hypertension. Indian Journal of Gastroenterology 2014; 33(4): 355 doi: 10.1007/s12664-014-0460-4
|